(Q44667547)

5 December 2017

title

Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional study (English)

1 reference

5 December 2017

Liron Pantanowitz

1

1 reference

5 December 2017

Gerry Bohac

2

1 reference

5 December 2017

Timothy P Cooley

3

1 reference

5 December 2017

David Aboulafia

4

1 reference

5 December 2017

Bruce J Dezube

5

1 reference

5 December 2017

publication date

2 April 2008

1 reference

5 December 2017

1 reference

5 December 2017

volume

101

1 reference

5 December 2017

issue

12

1 reference

5 December 2017

page(s)

1519-1523

1 reference

The growing problem of non-AIDS-defining malignancies in HIV.

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

Should HIV patients be considered a high risk group for the development of prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

The prostate as a reservoir for HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

Human herpesvirus 8 seroprevalence among prostate cancer case patients and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

The management of chronic prostatitis in men with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

Prostate carcinogenesis and inflammation: emerging insights.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

Prostate cancer in the post-transplant population. Urologic Society for Transplantation and Vascular Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

Prostate carcinoma among men with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

Cancer risk in elderly persons with HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

Risk of cancer in persons with AIDS in Italy, 1985-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

The risk of cancer in HIV-infected people in southeast England: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

Trends in cancer risk among people with AIDS in the United States 1980-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

Genitourinary manifestations of the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

Disseminated, lethal prostate cancer during human immunodeficiency virus infection presenting with non-specific features. Open questions for urologists, oncologists, and infectious disease specialists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

Approach to management of clinically localized prostate cancer in patients with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

Radical prostatectomy in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

Inflammation in prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

Serum prostate-specific antigen levels in older men with or at risk of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

Risk of cancers during interrupted antiretroviral therapy in the SMART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

Survival after cancer diagnosis in persons with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

Association of Cancer With AIDS-Related Immunosuppression in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07474.X

10.1111/J.1464-410X.2008.07474.X

21 January 2018

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dlc3skfbgncyraqzjnsunffz7y

mapped directly with Wikidata item

30 July 2022

based on heuristic

Fatcat ID

release_dlc3skfbgncyraqzjnsunffz7y

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dlc3skfbgncyraqzjnsunffz7y

mapped directly with Wikidata item

30 July 2022

based on heuristic

https://api.fatcat.wiki/v0/release/dlc3skfbgncyraqzjnsunffz7y

1 reference